BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1103947)

  • 1. Aspirin, haemostasis and thrombosis.
    O'Brien JR
    Br J Haematol; 1975 Apr; 29(4):523-7. PubMed ID: 1103947
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Why aspirin?
    Majerus PW
    Circulation; 1976 Sep; 54(3):357-9. PubMed ID: 947566
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of prostacycline, thromboxane A2 and prostaglandins in platelet aggregation (author's transl)].
    Herman AG
    Rev Med Brux; 1981 Mar; 2(3):251-7. PubMed ID: 7015444
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelets and thromboembolism.
    Aledort LM
    Semin Thromb Hemost; 1976 Jan; 2(3):136-45. PubMed ID: 798273
    [No Abstract]   [Full Text] [Related]  

  • 6. Interruption of thrombosis and hemostasis by anti-platelet agents.
    Shebuski RJ
    Toxicol Pathol; 1993; 21(2):180-9. PubMed ID: 8210940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aspirin resistance: position paper of the working group on aspirin resistance of the international society on thrombosis and haemostasis].
    Boskholov BP
    Kardiologiia; 2005; 45(7):75-6. PubMed ID: 16091668
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prostaglandins and platelet aggreation].
    Damas J
    Rev Med Liege; 1977 Nov; 32(21):670-5. PubMed ID: 594543
    [No Abstract]   [Full Text] [Related]  

  • 9. [Divergence between the pharmacologic and clinical effects of inhibitors of prostaglandin synthesis].
    Rhyner K; Stenger M; Block LH
    Dtsch Med Wochenschr; 1984 Aug; 109(31-32):1211-4. PubMed ID: 6430669
    [No Abstract]   [Full Text] [Related]  

  • 10. On the mechanism of platelet activation during hemostasis and thrombosis and on the effects of platelet inhibiting drugs.
    Breddin K; Bender N; Kirchmaier CM
    Adv Exp Med Biol; 1984; 164():145-54. PubMed ID: 6421101
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of aspirin on platelet aggregation as a function of dosage and time.
    Paccioretti MJ; Block LH
    Clin Pharmacol Ther; 1980 Jun; 27(6):803-9. PubMed ID: 7379449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis.
    Moncada S; Vane JR
    Br Med Bull; 1978 May; 34(2):129-35. PubMed ID: 350335
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin as an antithrombotic drug: from the aggregometer to clinical trials.
    de Gaetano G
    Verh K Acad Geneeskd Belg; 1990; 52(6):459-71; discussion 471-3. PubMed ID: 2150736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of the knowledge of prostaglandins for the odonto-stomatologist; their role in primary hemostasis and in inflammation].
    Maillard P
    Actual Odontostomatol (Paris); 1984 Mar; (145):95-120. PubMed ID: 6741664
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aspirin as a platelet antiaggregant: indications and controversies].
    Stalder M; Bachmann F
    Ther Umsch; 1987 Aug; 44(8):584-90. PubMed ID: 3313789
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of newer platelet function tests ot define abnormalities of hemostasis and thrombosis.
    Hoak JC; Wu KK; Fry GL
    Ser Haematol; 1975; 8(3):81-8. PubMed ID: 824740
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary thrombocyte reactions in hemostasis and thrombogenesis and the possibilities of influencing them by drugs].
    Breddin K
    Z Gesamte Inn Med; 1984 May; 39(10):234-41. PubMed ID: 6380127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of action of aspirin-like drugs.
    Moncada S; Vane JR
    Adv Intern Med; 1979; 24():1-22. PubMed ID: 371357
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemostasis in the microvasculature of the rabbit mesentery, effects of some pharmacological agents of current interest in haemostasis and thrombosis.
    Bergqvist D; Arfors KE
    Haemostasis; 1976; 5(2):74-84. PubMed ID: 950177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Various therapy options. Medical Chemistry of platelet aggregation inhibitors].
    Zettl H; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2009; 38(4):314-9. PubMed ID: 19572349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.